Check out our suggestions for Halloween fun that turn the spotlight away from the sugar treats and shift the emphasis to creativity and participation.

Halloween tends to set the tone for the rest of the holidays that cluster around the end of any year and the beginning of the next.

Pediatric obesity experts agree that behavioral interventions, used in conjunction with GLP-1 medications, can be more effective than a standalone tool.

Utilizing social media, women have taken it upon themselves to communicate with each other, sharing good news and bad news.

Some studies indicate that GLP-1 drugs in conjunction with pregnancy do pose a risk, but the FDA still warns women not to take them during pregnancy.

Obesity treatment has shifted away from advice about diet and exercise to a more scientific understanding of the disease.

Digital interventions are reshaping pediatric care across a range of conditions, including mental health and obesity management.

What is the one thing more disappointing than the fact that sugar is not good for us? Learning that sugar substitutes can also be very harmful.

September is the National Childhood Obesity News. To honor it, let’s look at some recent studies in various areas, from dengue fever to baby food nutrition.

One way or another, childhood obesity ends up being everybody’s problem. Agreement is universal on the importance of starting to fight it early.

A new study published in the New England Journal of Medicine sheds light on how GLP-1 drugs could play a critical role in treating obesity in younger children.

According to WHO, on the obesity scale, Japan ranks at #183 in the world, with only 4.94% of its adults obese. What’s the secret?

Is lack of elf-control to blame as one of the causes of childhood obesity. It’s a double-edged sword. Let’s take a look.

In two recent studies, Yale researchers try to identify ways to increase access to effective pediatric obesity treatments.

A child’s early experiences alter gene expression and affect long-term development whether we like it or not, and whether or not we believe it.

By selling weight-loss meds that only work as long as people are taking them, the companies guarantee that sales of GLP-1 drugs will continue into infinity.

Can berberine, a compound derived from plants, offer a safe alternative to widely-used weight loss medications?

A quick look at the life and work of Louie Anderson, who performed stand-up comedy for around 40 years, acted in films and on TV, and wrote five books.

A look at two reviews of the famous food critic Frank Bruni’s book, Born Round: The Secret History of a Full-Time Eater.

There are a few new obesity treatments being actively researched and developed. Let’s take a look.

On a global scale, and for many reasons, the happiest humans and the most overweight humans constitute very different populations.

Potential users of weight loss drugs are urged to verify the legitimacy of online pharmacies, but who knows how to do that?

Digital tools like Telemedicine and mHealth can be valuable for treating and preventing childhood obesity.

Will oral GLP-1s change the game and appeal to those turned off by injectables? According to experts, it depends.

Hesitancy and caution bring up questions like who exactly needs to take GLP-1 drugs for weight loss and whether they really need to.

The GLP-1 drugs have been around for a while, although mainly as a diabetes treatment. As weight-loss drugs, however, they are relatively new and untried.

About the GLP-1 drugs, there are currently more questions than answers, and one of them is, are the most important questions even being asked?

As weight-loss aids, GLP-1 drugs are relatively new and untried. When any discovery comes along, questions arise.

The loss of muscle mass that inevitably accompanies fat loss is a hazard to teens who are prescribed a GLP-1 drug. Not surprisingly, seniors are also at risk.

Some doctors who prescribe the GLP-1 meds have become alarmed by the disproportionate loss of muscle mass in their older patients.